Cerebrolysin vs Semax: Which Nootropic Peptide Does More for Your Brain?

Built by medical professionals, gym rats, and experienced biohackers

Quick Answer

Cerebrolysin is a mixture of peptides and neurotrophic factors derived from porcine brain tissue, delivered by injection. Semax is a fully synthetic peptide modeled on a fragment of ACTH, most often administered as a nasal spray. Both support brain-derived neurotrophic factor (BDNF) activity, but through different routes. Cerebrolysin brings preformed growth factors directly into the system; Semax signals the brain to produce more of its own.

What Is Cerebrolysin?

Cerebrolysin is a pharmaceutical-grade hydrolysate made from pig brain tissue. Processing removes fats and large proteins, leaving a concentrated solution of small peptides and free amino acids alongside neurotrophic factors including BDNF, NGF (nerve growth factor), CNTF (ciliary neurotrophic factor), and GDNF (glial cell line-derived neurotrophic factor) .

Mechanism: The small peptides cross the blood-brain barrier and act on neuronal survival, plasticity, and repair pathways. The neurotrophic factors support the growth and maintenance of neurons and synaptic connections.

Form and route: Liquid solution for intramuscular (IM) or intravenous (IV) injection. No oral or intranasal form has demonstrated comparable bioavailability.

Evidence level: Moderate to strong for certain applications. Multiple randomized controlled trials have examined its use in stroke recovery and Alzheimer's disease research contexts . It is a registered pharmaceutical in several European and Asian countries .

Typical research dose range: 5 mL to 30 mL per session, administered IM or IV . Protocols in published studies often run 10 to 20 consecutive daily sessions .

What Is Semax?

Semax is a synthetic heptapeptide. Its sequence extends the ACTH(4-7) fragment (Met-Glu-His-Phe) with a Pro-Gly-Pro tail that resists rapid enzymatic breakdown . It was developed in Russia and has been approved there as a nasal drug for certain neurological and vascular indications .

Mechanism: Semax upregulates BDNF expression in the hippocampus and cortex, modulates dopaminergic and serotonergic tone, and activates melanocortin receptors . Research also points to effects on serotonin uptake regulation and the HPA stress-response axis.

Form and route: Most commonly a nasal spray at 0.1% or 1% concentration. Injectable forms exist but are less common among self-directed researchers.

Evidence level: Moderate. The bulk of published literature comes from Russian institutions . A smaller body of international research is developing, though large-scale Western randomized controlled trials remain limited.

Typical research dose range: 200 mcg to 900 mcg per day intranasally, often divided across two daily applications . Many protocols center around 300 mcg to 600 mcg as a practical daily range .

Cerebrolysin vs Semax: Side-by-Side

Feature Cerebrolysin Semax
Type/form Porcine peptide hydrolysate, injectable solution Synthetic heptapeptide, nasal spray or injectable
Mechanism Delivers BDNF, NGF, GDNF, CNTF directly Upregulates BDNF, modulates dopamine and serotonin, activates melanocortin receptors
Typical research dose 5-30 mL IM/IV per session 200-900 mcg/day intranasal
Evidence level Moderate-strong (European and Asian RCTs) Moderate (primarily Russian literature)

Key Differences

1. Source: biological vs synthetic

Cerebrolysin is a biological product derived from animal tissue. Semax is fully synthetic. Researchers who prefer a precisely characterized peptide structure, or who have concerns about animal-derived compounds, often lean toward Semax on that basis alone.

2. Route of administration

Cerebrolysin requires a needle every session. Semax nasal spray is far simpler to self-administer and does not require sterile injection technique. This practical gap drives many people toward Semax when both compounds are otherwise comparable for their research goals. The injection requirement also makes Cerebrolysin better suited to supervised clinical or research settings.

3. BDNF pathway

Cerebrolysin delivers neurotrophic factors externally. Semax prompts the brain to synthesize more BDNF internally. Some researchers argue that endogenous upregulation produces more sustained plasticity effects. Others prefer the direct, measurable dose delivered by an injectable mixture. Neither position has definitive published support comparing outcomes head-to-head .

4. Tracking your protocol

Because cycle lengths, dosing schedules, and administration routes differ so much between these two compounds, good record-keeping is important. Many researchers use DoseVault to log their compounds, timing, and subjective responses so they can spot patterns and review their data over time.

5. Regulatory and supply context

Cerebrolysin holds drug status in Austria, China, Russia, and several Asian countries . Semax holds drug approval in Russia . Neither is FDA-approved for general consumer use in the United States. Both exist in a research-compound gray zone in most Western markets.

Can You Stack Them?

Some researchers combine Cerebrolysin and Semax within the same protocol. The reasoning is that Cerebrolysin provides direct neurotrophic support while Semax amplifies endogenous BDNF production. On paper, these mechanisms are complementary rather than overlapping.

In practice, published data specifically on the combination is scarce . Both compounds act on overlapping neurological targets, making it difficult to predict additive or synergistic effects without formal study data.

The most important step before stacking is consulting a licensed clinician. Individual neurological baseline, cardiovascular status, and concurrent medications all factor into whether a combined protocol is appropriate for a given person. This is not a decision to make from a forum post.

Frequently Asked Questions

What is the difference between Cerebrolysin and Semax?
Cerebrolysin is a peptide mixture derived from porcine brain tissue that directly delivers neurotrophic factors including BDNF and NGF. Semax is a synthetic peptide based on the ACTH(4-7) sequence that upregulates BDNF production and modulates dopamine and serotonin systems. Cerebrolysin requires injection, while Semax can be administered intranasally.

Can Cerebrolysin and Semax be stacked together?
Some researchers use both compounds within the same protocol, reasoning that they target BDNF through complementary pathways. However, published data on the combination is limited. Always consult a licensed clinician before stacking these or any compounds.

How is Cerebrolysin administered compared to Semax?
Cerebrolysin is given by intramuscular or intravenous injection only. Semax is most commonly used as a nasal spray, though injectable forms also exist. The intranasal route makes Semax more accessible for many researchers.

Which has more research support, Cerebrolysin or Semax?
Both have moderate evidence bases. Cerebrolysin has more published trials in Western and European literature examining stroke recovery and neurodegenerative conditions. Semax has a substantial body of research primarily from Russian institutions, where it holds drug approval for certain neurological indications.

Who Picks Each, and When?

Cerebrolysin tends to suit researchers who:
- Have access to a supervised clinical or medical setting where IV or IM administration is available
- Want direct delivery of multiple neurotrophic factors rather than relying on endogenous upregulation
- Are researching neuroprotection, post-injury recovery, or neurodegeneration support
- Can source pharmaceutical-grade product from licensed suppliers

Semax tends to suit researchers who:
- Prefer intranasal administration over injections
- Want a fully synthetic, precisely characterized peptide with no animal-derived components
- Are exploring cognitive function, attentional focus, or stress-axis modulation
- Need a more flexible daily-use protocol rather than intensive short injection courses

Related


Disclaimer: This content is for educational purposes only. It is not medical advice. Cerebrolysin and Semax are not FDA-approved for general consumer use. Never start, stop, or modify use of any compound without consulting a licensed healthcare provider.

Built by medical professionals, gym rats, and experienced biohackers


Ready to track your nootropic peptide research with a purpose-built tool? DoseVault lets you log compounds, doses, timing, and notes in one place, so your data works for you over time. Free to start.